Skip to content

GLUEMONTE ROSA THERAPEUTICS INC

CUSIP 61225M102 · common stock

3 tracked investors held MONTE ROSA THERAPEUTICS INC (GLUE) at the end of Q3 2026, worth $67.4M in total. The largest holder was Julian Baker, with 0.2% of its portfolio. Stanley Druckenmiller sold out of its position this quarter.

Holders · Q3 2026
3
New holders
0
Value held
$67.4M
Quarter-end price (est.)
$11.93

Investors holding GLUE · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
0.25%4,345,736$51.8MHOLD
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.51%1,007,752$12MADD+364.9%
Ken Fisher
Fisher Asset Management, LLC
0.00%295,844$3.5MREDUCE-18.6%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Stanley Druckenmiller0.14%297,600$7.2MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026301$67.4M$11.93
Q2 2026410$126.4M$24.20
Q1 2026310$80.2M$16.45
Q4 2025200$71.5M$15.68